Gradient vs. Flow to Determine Aortic Valve Stenosis Severity before and after TAVR

Pressure loss vs. flow curves offer a fundamental synthesis of fluids dynamics in describing aortic valve physiopathology. Severe aortic stenosis is not just an orifice (as suggested by Gorlin) or a segment that offers dynamic resistance. However, once a new transcatheter valve has been implanted, it will behave purely as a resistor.

gradiente vs flujoAt dobutamine dose, the ratio of aortic to left ventricular pressures during systolic ejection are a sort of “fractional flow reserve” of the aortic valve that closely resembles the complex dynamics of flows produced in this segment.

 

Since resting assessment of gradients or flows cannot accurately predict stress hemodynamics, we need this “valvular fractional flow reserve” to explain stress symptoms in patients with moderate stenosis at rest.  


Read also: TAVR in Patients with Classical Low Flow, Low Gradient.


Echocardiography and computer tomography can document dynamic changes and stenosis geometry and severity during both the resting cardiac cycle and the stressed induced increase in cardiac output. However, the correlation between gradient vs. flow has not yet been described.

 

The study included 16 patients undergoing TAVR to dobutamine infusion while 0.014” pressure wires in the aorta and left ventricle registered transvalvular pressure gradient.  Simultaneously, a Swan Ganz catheter assessed cardiac output by thermodilution. This was done before and after TAVR.

 

Neither the linear resistor nor the quadratic orifice model at rest predicted stress observations.


Read also: Which Low-Flow, Low-Gradient Patients Benefit from Valve Replacement?


Aortic to left ventricular pressure ratio during systolic ejection under stress conditions with dobutamine was what best correlated with post TAVR flow improvement.

 

After TAVR, a highly linear relationship indicates the prosthetic valve behaves as a resistor.

 

Original title: Pressure gradient vs. flow relationships to characterize the physiology of a severely stenotic aortic valve before and after transcatheter valve implantation.

Reference: Nils P. Johnson et al. European Heart Journal (2018) 39, 2646–2655.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....